| Persistent immune imprinting occurs after vaccination with the COVID-19 XBB. 1.5 mRNA booster in humans MA Tortorici, A Addetia, AJ Seo, J Brown, K Sprouse, J Logue, E Clark, ... Immunity 57 (4), 904-911. e4, 2024 | 9 | 2024 |
| Broadly neutralizing antibodies against emerging delta-coronaviruses M Rexhepaj, YJ Park, L Perruzza, D Asarnow, M Mccallum, K Culap, ... bioRxiv, 2024 | | 2024 |
| Human coronavirus HKU1 recognition of the TMPRSS2 host receptor M McCallum, YJ Park, C Stewart, KR Sprouse, J Brown, MA Tortorici, ... BioRxiv, 2024 | 2 | 2024 |
| Persistent immune imprinting after XBB. 1.5 COVID vaccination in humans MA Tortorici, A Addetia, AJ Seo, J Brown, KR Sprouse, J Logue, E Clark, ... Biorxiv, 2023 | 7 | 2023 |
| Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape R Marzi, J Bassi, C Silacci-Fregni, I Bartha, F Muoio, K Culap, ... Iscience 26 (1), 2023 | 9 | 2023 |
| Close relatives of MERS-CoV in bats use ACE2 as their functional receptors Q Xiong, L Cao, C Ma, MA Tortorici, C Liu, J Si, P Liu, M Gu, AC Walls, ... Nature 612 (7941), 748-757, 2022 | 70 | 2022 |
| SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines JE Bowen, YJ Park, C Stewart, JT Brown, WK Sharkey, AC Walls, A Joshi, ... Science Immunology 7 (78), eadf1421, 2022 | 38 | 2022 |
| ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies JS Low, J Jerak, MA Tortorici, M McCallum, D Pinto, A Cassotta, ... Science 377 (6607), 735-742, 2022 | 94 | 2022 |
| Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies (vol 593, pg 136, 2021) DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... NATURE 608 (7922), E24-E24, 2022 | | 2022 |
| Author Correction: Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 608 (7922), E24-E24, 2022 | 2 | 2022 |
| 1 2 3 4 5 6 7 8 9Lead contact* Correspondence: https://doi. org MA Tortorici, AC Walls, A Joshi, YJ Park, RT Eguia, MC Miranda, E Kepl, ... CELL 185 (13), 2279-+, 2022 | | 2022 |
| Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein MA Tortorici, AC Walls, A Joshi, YJ Park, RT Eguia, MC Miranda, E Kepl, ... Cell 185 (13), 2279-2291. e17, 2022 | 34 | 2022 |
| ACE2 engagement exposes the fusion peptide to pan-coronavirus neutralizing antibodies JS Low, J Jerak, MA Tortorici, M McCallum, D Pinto, A Cassotta, ... bioRxiv, 2022.03. 30.486377, 2022 | 8 | 2022 |
| SARS-CoV-2 spike conformation determines plasma neutralizing activity JE Bowen, AC Walls, A Joshi, KR Sprouse, C Stewart, MA Tortorici, ... BioRxiv, 2021 | 19 | 2021 |
| Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines AC Walls, MC Miranda, A Schäfer, MN Pham, A Greaney, ... Cell 184 (21), 5432-5447. e16, 2021 | 149 | 2021 |
| Broad betacoronavirus neutralization by a stem helix–specific human antibody D Pinto, MM Sauer, N Czudnochowski, JS Low, MA Tortorici, MP Housley, ... Science 373 (6559), 1109-1116, 2021 | 291 | 2021 |
| Broad sarbecovirus neutralization by a human monoclonal antibody MA Tortorici, N Czudnochowski, TN Starr, R Marzi, AC Walls, F Zatta, ... Nature 597 (7874), 103-108, 2021 | 208 | 2021 |
| SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape TN Starr, N Czudnochowski, Z Liu, F Zatta, YJ Park, A Addetia, D Pinto, ... Nature 597 (7874), 97-102, 2021 | 403 | 2021 |
| SARS-CoV-2 immune evasion by the B. 1.427/B. 1.429 variant of concern M McCallum, J Bassi, A De Marco, A Chen, AC Walls, J Di Iulio, ... Science 373 (6555), 648-654, 2021 | 510 | 2021 |
| Structural basis for broad coronavirus neutralization MM Sauer, MA Tortorici, YJ Park, AC Walls, L Homad, OJ Acton, ... Nature structural & molecular biology 28 (6), 478-486, 2021 | 164 | 2021 |
